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Objective: To examine the secular effects of opportunistic screening for cervical cancer in a rich,
developed community where most other such populations have long adopted organised screening.
Design, setting, and participants: The analysis was based on 15 140 cases of invasive cervical cancer
from 1972 to 2001. The effects of chronological age, time period, and birth cohort were decomposed
using both maximum likelihood and Bayesian methods.
Results: The overall age adjusted incidence decreased from 24.9 in 1972–74 to 9.5 per 100,000 in
1999–2001, in a log-linear fashion, yielding an average annual reduction of 4.0% (p,0.001) during the
30 year period. There were two second order and thus identifiable changes: (1) around the mid-1920s
cohort curve representing an age-period interaction masquerading as a cohort change that denotes the
first availability of Pap testing during the 1960s concentrated among women in their 40s; (2) a hook
around the calendar years 1982–83 when cervical cytology became a standard screening test for
pregnant women.
Conclusions: Hong Kong’s cervical cancer rates have declined since Pap tests first became available in the
1960s, most probably because of increasing population coverage over time and in successive generations
in a haphazard fashion and punctuated by the systematic introduction of routine cytology as part of
antenatal care in the 1980s.
A
nalysis of secular trends in cancer epidemiology is
important to the understanding of disease aetiology
and for the assessment of public health control policy.
Despite the availability of effective primary and secondary
prevention—that is, cytological screening since the 1960s—
cervical cancer remains an important cause of morbidity and
mortality worldwide. Hong Kong provides a contemporary
setting to study the secular effects of opportunistic screening
for cervical cancer. It is one of very few communities
worldwide at an advanced stage of socioeconomic develop-
ment and with some of the best basic health indices in the
world,1 but does not have an organised population based
screening programme. Thus Hong Kong’s experience may
illustrate the population impact of opportunistic uptake of
cervical cytological smears. It can also act as a reliable
epidemiological harbinger for mainland China as it rapidly
transits through socioeconomic development in the coming
decades.
Age-period-cohort (APC) models, as well as age-period
(AP) and age-cohort (AC) models, have been used exten-
sively in the literature to describe disease trends in popula-
tions,2–6 and in particular for cervical cancer.7 8 We present
here a longitudinal analysis of cervical cancer incidence rates
in Hong Kong from 1972 through 2001, using APC methods
to decompose the independent effects of chronological age,
time period, and birth cohort. In particular, we analysed the
data using both the frequentist maximum likelihood
approach as well as Bayesian methods.
METHODS
Sources of data
Data on cervical cancer incidence were obtained from the
Hong Kong Cancer Registry. Details of the history, objectives,
logistics, and registration coverage of the cancer registry are
reported elsewhere.9 Briefly, the Hong Kong Cancer Registry
is a population based registry covering the entire resident
population of Hong Kong. Information on cervical cancer
cases were collected from both the private and public service
sectors (mainly through departments of clinical and radiation
oncology and histopathology), and from the government’s
Births, Deaths and Marriages Registry, as well as voluntary
notification from all medical practitioners. The completeness
and quality of the data has been reported to be good, with
over 95% coverage for most cancers although there has not
been detailed audits for each cancer specifically, especially in
the past 20 years although like most other such registries
worldwide there was probably relative underreporting in the
1970s compared with the post-1980 period.9 The Hong Kong
Cancer Registry is an accredited member of the International
Association of Cancer Registries. Data on mid-year popula-
tion statistics were derived from the government’s Census
and Statistics Department.
These analyses were based on 15 140 cases (of a total of
15 238 cases where the age at diagnosis was unknown in 98
cases) of invasive cervical cancer (International Classification of
Disease 8th edition (ICD-8) and ICD-9 code 180) reported from
all medical institutions in Hong Kong during a 30 year period
from January 1972 to December 2001.
Statistical analysis
Age adjusted incidence rates were calculated by direct
standardisation according to the World Standard
Population and expressed per 100 000 female population.10
To explore the effects of calendar time period and cohort on
disease trends, we plotted age specific incidence by year of
diagnosis (that is, cancer registration) and of birth.
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Maximum likelihood approach
Secular trends in cervical cancer incidence based on annual
data were first examined with a simple log-linear regression
model. This model formed the basis for the estimates of
average annual percentage change (AAPC) in incidence rates
with time periods. A two tailed test of statistical significance
was applied to the AAPC.11 The second order polynomial
model with a quadratic trend term was also constructed to
test for possible non-linear trends.
We further analysed the independent effects of chronolo-
gical age, time period,and birth cohort on cervical cancer
incidence trends using APC modelling. Cases were grouped
into five year age groups (from 25–29 years to 80–84 years).
There were very few cases in the age groups below 25 years or
above 85 years and resultant rates were unstable, we
therefore omitted these age groups from the analysis.
Similarly, the time period of diagnosis were divided into five
year intervals from 1972–76 to 1997–2001. A two way table of
age group by time period was constructed giving a total of 12
age groups, six time periods, and 17 synthetic birth cohorts
(on the diagonals from left to right, starting with each of the
12 age groups in the earliest time period of 1972–76, then five
additional birth cohorts for each of the remaining time
periods) (table A1 in the appendix).
To obtain the effects of age, period, and cohort, a log-linear
model was fitted to the data by assuming a Poisson
distribution for the observed number of cervical cancer cases,
and that incidence rates are a multiplicative function of the
model parameters.12–15 Let cij be the observed cases for age
group i in time period j. We assumed that it follows a Poisson
distribution with mean mij, that is, cij , Poisson (mij) and we
modelled the mean as:
where ai is the age effect (i = 1, …, I), bj is the period effect
(j = 1, …, J) and ck is the cohort effect (k = 1, …, K where
k = I+j2i and K = I+J21); nij denotes the total number of
person years for age group i in time period j; and eij is the
random error term.
The parameter estimates were the maximum likelihood
estimates. In our study, the calendar period 1977–81 and birth
cohort with central year of birth 1922 were adopted as reference
categories. A sequence of models was fitted to the data, starting
with the single factor age model, then the two factor age drift,
AP and AC model and the full three factor APC model.
A fundamental problem of the APC modelling is the non-
identifiability problem when all the three variables, namely,
age, period, and birth cohort are included into the model
simultaneously. The three variables are not independent
(cohort = period – age) such that the chosen solution to the
model is not unique, although each set of solution produces
the same fitted rates. The technique adopted in this paper
had been commonly used in several previous studies.6 16 17
Specifically, the regression coefficients of the first and last
period were both constrained to be zero, the first order
relative risk estimates for the cohort effects can thus be
estimated for a particular set of APC parameters. Likewise,
the regression coefficients of the first and last cohorts were
constrained to equal zero thereby obtaining relative risks for
the period effects.
The deviance of the model was used as a measure of the
goodness of fit. It is the log-likelihood ratio statistic
Table 1 Age specific average annual percentage change (AAPC) of cervical cancer
incidence in Hong Kong, 1972–2001
Age (years)
Linear model Model with a quadratic trend term
AAPC for
1972–2001 (%) p value Sign of the second order term p Value
25–29 23.54 0.001 2 0.51
30–34 24.10 ,0.001 + 0.68
35–39 23.99 ,0.001 2 0.87
40–44 24.32 ,0.001 2 0.36
45–49 24.75 ,0.001 2 0.14
50–54 24.34 ,0.001 2 0.84
55–59 24.65 ,0.001 2 0.001
60–64 24.16 ,0.001 2 ,0.001
65–69 22.99 ,0.001 2 0.18
70–74 22.23 ,0.001 2 0.001
75–79 21.20 0.02 + 0.15
80–84 0.001 0.90 2 0.06
85+ 22.12 0.01 + 0.38
25–84 24.20 ,0.001 2 0.46
Age standardised 23.95 ,0.001 2 0.01
Table 2 Summary statistics comparing goodness of fit for different cervical cancer
maximum likelihood models
Model Degrees of freedom Deviance p Value* Adjusted R2
Age 60 1805.2
Age drift ` 59 270.9 0.85
Age period 55 214.6 ,0.001 0.87
Age cohort 44 111.0 ,0.001 0.92
Age-period-cohort 40 68.5 0.94
*p Values are based on the F test for comparisons between two factor model with the full age-period-cohort
model.18 Adjusted R2 measures how much of the variability that is explained by factors other than age, taking into
account the difference in the numbers of degrees of freedom.15 `The ‘‘drift’’ parameter represents a log-linear
change in rate not exclusively identifiable as a period or cohort effect.
Cervical cancer incidence in Hong Kong 713
www.jech.com
 on 1 March 2007 jech.bmj.comDownloaded from 
comparing the fitted model with the model with a perfect fit
(one parameter per observation in the dataset). The presence
of second order period or cohort effects was tested by
comparing the change in deviance between the respective
models and the full APC model using the F test.18 For
instance, when testing for the importance of cohort effects, a
substantial change in the deviance between the AP model
and the APC model implies a significant contribution of
cohort effects; and similarly for testing the added contribu-
tion of period effects. This set of statistical analyses was
performed using SAS version 8.02.
Bayesian approach
For comparison purposes, we also applied the Bayesian
framework to the APC modelling. The Bayesian approach
combines prior knowledge with observed data to derive a
posterior distribution (posterior distribution 3 prior dis-
tribution 6 likelihood), from which we can draw inferences
about parameters or functions of the parameters. The
analysis was based on single calendar years (but still five
year age groups).
A hierarchical model was assumed with a binomial model
in the first stage: cij , Binomial (nij, pij) such that the classic
APC model could be adopted which decomposes the log odds
additively into an overall m level, age
effects ai (i = 1, …, I), period effects bj (j = 1, …, 5J) and
cohort effects ck (k = 1, …, K where k = 5(I2i)+j and
K = 5(I+J21):
The parameters a, b, and c were given prior distributions to
obtain posterior distributions through simulations rather
than analytically. Trends corresponding to age, period, and
birth cohort were smoothed using a first order random walk
model to constrain parameter estimates from deviating
excessively from those in adjacent time bands19:
where the hyperparameter k was a precision parameter
determining the smoothness of the age effects. The same
type of prior was used for the period and cohort parameters b
and c with precision parameters l and v respectively. The full
conditionals for the age, period, and cohort effects thus
followed a multivariate Gaussian distribution. These dis-
tributions were rewritten into a linear Gaussian state space
model for efficient implementation.19
This model was implemented using the software BAMP
(BAMP v1.3.0). Parameter estimates and 90% credible
intervals were obtained by Markov chain Monte Carlo
simulations in state-space models. The simulations were
run for 1 010 000 iterations with the initial 10 000 iterations
used as burn-in to minimise the effect of initial values.
Highly non-informative values were chosen for the hyper-
priors of the precision parameters k, l and v, namely,
Gamma(1, 0.0005).
RESULTS
Age standardised as well as age specific trends in incidence
rates over the entire period of observation were plotted on a
logarithmic scale in figure 1. For clarity of presentation, only
data for every other five year age group are shown. The
overall age adjusted incidence decreased from 24.9 in 1972–
74 to 9.5 per 100 000 in 1999–2001, in a log-linear fashion.
This incidence decline in time was evident in all age groups
(except in those 80 years and above). Figure 2 presents the
age specific incidence by 10 year birth cohorts where the
parallelism in the curves shows decreasing incidence with
each successive generation.
Assuming that the rate of change was constant throughout
the observed period, we computed the AAPC from a simple
log-linear regression model (table 1). The overall age
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Figure 1 Age standardised (world
standard population) and selected age
specific incidence rates for cervical
cancer by year of diagnosis in Hong
Kong, 1972–2001.
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standardised incidence decreased annually by 4.0% during
the 30 year period. Significant negative changes were
registered in almost all age groups ranging from 24.8% to
21.2%, except for the 80 and above age group. With non-
statistically significant exceptions in only two age groups, the
second order quadratic terms were uniformly negative for all
other age specific strata and overall. The negative coefficient
of the quadratic term attempts to take into account the initial
increase in rates in the early 1970s (and subsequent steady
decrease after around 1977).
Maximum likelihood APC models were fitted to the data
from 1972 to 2001. Table 2 shows the change in deviance
(that is, showing goodness of fit) in the sequential building
of the models. Both the AP and AC models significantly
improved the fit over the age only and age drift models. The
full three factor model was in turn significantly better than
the two factor AP (p,0.001) and AC (p,0.001) models as
shown by the F test.
Figure 3 compares relative risks calculated by time period
and birth cohort based on two separate full APC models with
period and cohort constraints imposed with Bayesian poster-
ior estimates of the APC parameters. The slope of the time
period effects curve decreased in the late 1970s. Similarly,
with the exception of the earliest birth cohort with central
year of birth in 1892, the slope of the birth cohort effects
curve also declined. We obtained mostly consistent results
under the Bayesian analytical framework. The age parameter
shows the typical decelerating rise where the slopes were
steepest for young women and progressively levelled off in
the older age groups. Period effects show a log-linear decline
from the second five year period beginning in 1977. The
Bayesian estimates suggest that there may have been an
additional short term second order, and thus identifiable,
change in period effects—the hook caused by an upturn in
rates in 1982 and 1983. Both the maximum likelihood and
Bayesian birth cohort curves show one other clear identifiable
change—that is, the decrease in slope around 1920. The
possible increase in cohort slope in the early 1960s is not as
evident in the maximum likelihood estimates as in the
Bayesian estimates (the smoothing of the Bayesian method
makes this change look much more evident than is
warranted based on age specific rates), and given the
variability of estimates for recent cohort effects because of
the comparatively smaller number of cases as these women
would not have borne the full potential cancer burden yet,
may or may not reflect an actual change.
Figure A1 in the appendix shows the observed and fitted
number of incident cervical cancer cases with associated 90%
credible regions by alternate five year age groups in different
panels. Visual inspection shows that the model fit was
generally good, except in the extremes of age where there
were comparatively fewer cases. Quantitatively assessing
model fit,19 the median posterior deviance ranged from 351 to
396, which were very close to the asymptotically optimal
value of 360 ( = 12630)—that is, the number of observations
entered into the model.
DISCUSSION
We found that the overall age standardised incidence of
cervical cancer had recorded statistically significant average
annual decreases of 4.0% in the period of observation. The
reduction was more pronounced for those aged 30 to 65 years
although women of all ages showed some incidence decline.
While age is positively associated with cancer rates, figures 1
and 2 confirm that both calendar period and birth cohort
trends have been decreasing throughout the duration of
observation. Thus although the linear period and cohort
slopes in the full APC models are not identifiable because
they were separately constrained to be zero in the methods to
derive the other set of estimates, we can conclude that the
observed negative trends for calendar period and birth cohort
in figure 3 are in fact real.
Interpretation of APC analyses is difficult largely because
of the lack of good data on trends in risk factors or medical
practice. While definitive inferences about the impact of Pap
testing on cervical cancer rates should ideally be based on
both additional years of incidence data (for example,
incidence rates beginning in 1960 or earlier) and detailed
quantitative information on secular trends in Pap test use by
age, neither are available in Hong Kong (or indeed most
countries) for such a long time series but this should not
preclude educated postulation of plausible hypotheses as we
set out as follows.
Two second order and thus identifiable changes in the
period and cohort effect curves merit special attention, as
indicated by the inflection points (1) centred around the
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Figure 2 Age specific incidence of
cervical cancer by birth cohort.
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mid-1920s on both the maximum likelihood and Bayesian
birth cohort curves and (2) for the calendar years 1982–3 on
the Bayesian period curve (fig 3).
Women born in the 1920s were the first to have had an
opportunity to be screened when they were in their 40s
(around 1960s) with the advent of the Pap smear that was
available in Hong Kong soon after its introduction in the
West. This is the same age group who are the most likely to
have been screened (fig A2 in the appendix). Therefore,
although the introduction of an efficacious detection method
such as screening Pap smear would ordinarily be expected to
appear as a change in the period effects curve, it is possible
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Figure 3 Maximum likelihood and
Bayesian posterior median estimates for
age, period, and cohort parameters in
the cervical cancer incidence model.
RR, relative risk.
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that an age-period interaction masqueraded as the observed
cohort change if most of those screened (and benefited from
such) when Pap smears became available in the 1960s were
concentrated in the then 40 year olds (that is, belonging to
the 1920s birth cohorts). Moreover, the time series of cancer
registration did not stretch back far enough to the 1960s to
detect this expected change in the period slope. We are
additionally hampered by underregistration of cases in the
early years of operation of the Hong Kong Cancer Registry.
Probable underregistration of cancer cases in the 1970s could
explain the consistent observation in both the Bayesian and
maximum likelihood models that period effects in the early
to mid-1970s seemed to be more dampened than would
otherwise be expected if recent trends were backwards
extrapolated. Such underreporting has been widely recog-
nised and previously acknowledged. Nevertheless, such a
phenomenon would most probably have been non-differen-
tial given Hong Kong’s universal access to and market share
dominance of the public sector since the 1960s and therefore
would not have posed any significant threat to validity.
However, given the lack of detailed coverage data from audits
over time, it is impossible to adjust our results to formally
take this into account.
Regarding the second identifiable change in the period
slope, it probably represents an initial, transient increase in
rates due to ‘‘harvesting’’, coinciding with the time of the
introduction of systematic antenatal screening in the early
1980s and therefore a sudden surge in population coverage.
This period change in screening practice punctuates a
sustained log-linear decrease in cancer rates since the 1970s
(more probable since the 1960s although there are no data to
quantitatively substantiate such as discussed above) up to the
present (fig A1 and table A1 in the appendix).
According to the 2003 population household survey,20 only
42.3% of local women aged at least 21 years reported ever
being screened by cytological smear, of whom 99.6% were
tested in the previous five years and 57.2% attended on a
regular basis. Two other independent population surveys in
1997–821 and 200322 corroborate these statistics. However,
there is strong qualitative evidence to suggest that starting
from the early 1980s most Hong Kong women had received a
Pap smear as part of routine antenatal care, although a
substantial number did not apparently realise it. Given that
over 90% of all local pregnant women had received at least
one episode (median roughly 2.5) of antenatal care since the
early 1980s,23 we adjusted the proportion ever screened to
take into account this probable underreporting by reassigning
a positive ever screened response to all women who reported
no screening, were ever pregnant resulting in a live birth
since 1980, and belonged to birth cohorts with central year of
birth in 1950 or later, assuming a median age of first
pregnancy at 29 years.24 Figure A2 in the appendix shows that
the potential magnitude of underreporting was large where
the overall adjusted ever screening rate increased to 60.6%.
This figure represents an upper limit because not all pregnant
mothers received antenatal care, nor would every one have
received a Pap smear during antenatal visits, and not all
women would have underreported Pap screening as part of
routine antenatal care. In comparison, screening penetration
rates had reached 75% (enrolled in national every five year
screening program) in Finland by 1975,25 85% (ever screened
among those aged at least 15 years) in Canada by 1985,26 88%
(ever screened among those aged at least 18 years) in the
USA by 1987,27 and 85% (screened at least once within five
years) in the UK by 1995.28
Since the establishment of human papillomavirus (HPV)
as a necessary cause of cervical cancer in the 1990s,29 disease
risk should be examined from the perspective of mediating
viral infection or modulating events in the natural history of
cervical neoplasia after HPV acquisition.30 Considering
relevant markers of sexual activity, in Hong Kong as
elsewhere, the mean age of first sexual activity has been
decreasing while the number of premarital sexual partners
and the proportion who reported having premarital sex both
increased, according to routine sexual health surveys
conducted by The Family Planning Association of Hong
Kong since the late 1960s.31 In tandem with progressively
more liberal sexual practices, current male condom use has
increased by a whole order of magnitude from 3.5% among
15 to 49 year olds in 1972 to 37.8% in 1997.32 This might have
buffered against an even bigger epidemic of HPV infection,
which is as common in Hong Kong women as for others
worldwide where a bimodal age dependent point prevalence
profile is characteristic. In Hong Kong and other western
countries, about one fifth of young women in their 20s are
typically infected; the prevalence then declines through their
30s and 40s only to peak again during the sixth decade to
about 10%.33 34 In terms of the distribution of HPV subtypes in
Hong Kong, HPV-16 were isolated in 61.7% and HPV-18 in
14.8% of cervical cancer patients in a large consecutive case
series,35 which are similar to overseas figures reported by the
International Biological Study on Cervical Cancer (IBSCC)
study group.36 However, subtypes 58 and 52, comparatively
rare in the rest of the world, were found to be the third and
fourth commonest genotypes in Hong Kong and China.35
These two strains are phylogenetically similar to subtypes 16,
31, 33, 35, and 67, which may show similar pathogenic
What this paper adds
N Whereas most rich, developed countries have long
adopted organised cervical cytology screening, Hong
Kong provides a unique, contemporaneous setting to
study the secular effects of opportunistic screening that
can be compared with overseas settings at an
advanced stage of socioeconomic development as well
as forewarn the coming epidemiological transition
facing mainland China.
N The secular decline of cervical cancer rates in Hong
Kong can be similarly attributed to both period and
cohort effects, in contrast with the dominant impact of
inter-generational change in most other populations.
N We propose that Hong Kong’s cervical cancer rates
have declined since Pap tests first became available in
the 1960s because of increasing population coverage
over time and in successive generations largely in a
haphazard fashion and punctuated by the systematic
introduction of routine cytology as part of antenatal
care in the 1980s.
Policy implications
Hong Kong’s experience bears enormous policy significance
for mainland China as modernisation and rapid socio-
economic transition, from the eastern coastal provinces
moving westwards inland, will probably bring about
increasing availability of opportunistic screening. However,
while overall population coverage is an important indicator
of public health success, policymakers should be sensitive to
and guard against the potential for the inverse care law in
screening uptake.
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potential. Thus the higher sexual behavioural risk in
successive generations (resulting in similar profiles of HPV
infection prevalence in the general population and specific
subtypes among cancer patients between Hong Kong and
other western populations) in itself would have led to an
increase in cervical cancer rates in contrast with the overall
decline as seen. This suggests the presence of other counter-
effects, such as screening as shown by the two identifiable
changes as previously explained, on the population level that
have been driving down cervical cancer rates.
Therefore, we propose that Hong Kong’s cervical cancer
rates have come down steadily since the 1960s when Pap
tests first became available, because of increasing population
coverage over time and in successive generations largely in a
haphazard fashion and punctuated by the systematic
introduction of routine cytology as part of antenatal care in
the 1980s. It has long been argued that opportunistic
screening can reduce cervical cancer rates, but probably not
to the extent of organised programmes.37 38 It is unclear by
how much Hong Kong’s incidence will further decrease after
the introduction of the population based recall programme in
2004 (that is, its marginal effect in addition to the population
impact of the status quo of opportunistic screening) although
we do not anticipate the magnitude to be as substantial as
historically (see appendix for further details on the recall
programme). Taking reference from the experience of
England and Wales, Peto and colleagues39 argued that the
42% decrease in cervical cancer incidence between 1988 and
2000 in the UK was directly attributable to its National
Health Service Cervical Screening Programme launched in
1988. Whether Hong Kong can achieve a similar relative
decrease in incidence rates after organised screening should
be prospectively evaluated.
Comparing the two statistical approaches undertaken in
this study, a priori, Bayesian inference may offer a more
robust approach to model estimation, especially when there
are only sparse data, than the classic approach of maximum
likelihood that depends on the assumption of asymptotic
normality. The sampling based method of Bayesian estima-
tion also provides a full distributional profile of the
parameters and can take into account additional unstruc-
tured heterogeneity.19 Empirically, we showed that our
findings are consistent between and robust to the two
estimation methods. Hence this lends added credence to the
validity of our data.
A potential caveat regarding histological subtypes of
cervical cancer and the interpretation of disease trends bears
mention. It has been suggested that cytological screening
may be less effective in detecting adenocarcinoma compared
with squamous tumours.40 41 Unpublished data from the
American College of Pathologists accredited cervical cyto-
pathology laboratory of Queen Mary Hospital, a high volume
tertiary referral facility show that there was little difference
in adenocarcinoma incidence as a proportion of all invasive
cancers diagnosed between 1993–6 (22.2%) and 2000–3
(21.8%) (unpublished data from ANYC, gynaecological
pathologist in charge of review of oncology cases).
However, there was a relative increase in the proportion of
carcinoma of mixed histological differentiation (adenosqua-
mous) from 3.6% to 4.9% and other rare tumours (for
example, mucoepidermoid tumours, melanoma, sarcoma)
from 1.3% to 1.8% as a percentage of all invasive tumours.
Although longer term or more population based data on
histological subtypes are lacking, the available information
do not seem to substantiate the previous observation
although it could well be attributable to the as yet suboptimal
impact of haphazard screening in reducing the burden of the
dominant type squamous tumours, hence the relative
proportion of the much less common adenocarcinoma
remains small and static in comparison.
It is important to bear in mind that our interpretation of
the findings should be treated as hypotheses to be further
examined with other study designs and in different settings
because it is difficult to evaluate such on the basis of non-
experimental evidence, especially on the ecological level.
Nevertheless, Hong Kong’s experience has provided informa-
tive lessons on the natural history of opportunistic screening
and its secular effects in a developed Chinese population.
Finally, Hong Kong’s experience bears enormous policy
significance for mainland China. Given the present state of
health care financing and delivery, which is mostly devolved
and unregulated, China is unlikely to be able to centrally plan
and implement an organised screening programme with
adequate national or even regional coverage. Nevertheless, as
modernisation and rapid socioeconomic transition from the
eastern coastal provinces moving westwards inland will
probably bring about increasing availability of opportunistic
screening, our findings show that it may be possible to
achieve a sustained reduction in cervical cancer incidence
burden, given that an intact and functional management
infrastructure for screen positive cases exists. However, while
overall population coverage is an important indicator of
public health success, policymakers should be sensitive to
and guard against the potential for the inverse care law in
screening uptake.
ACKNOWLEDGEMENTS
This work formed part of the thesis requirements for PPSW’s doctoral
studies at the University of Hong Kong. GML thanks the Takemi
Program at the Harvard School of Public Health for hosting his
sabbatical leave during which manuscript preparation for this project
was completed.
Authors’ affiliations
. . . . . . . . . . . . . . . . . . . . .
G M Leung, P P S Woo, S M McGhee, T Q Thach, Department of
Community Medicine and School of Public Health, University of Hong
Kong, Hong Kong, China
A N Y Cheung, Department of Pathology, University of Hong Kong
S Fan, The Family Planning Association of Hong Kong, Hong Kong,
China
O Mang, Hong Kong Cancer Registry, Hospital Authority, c/o
Department of Clinical Oncology, Queen Elizabeth Hospital, Hong
Kong, China
H Y S Ngan, Department of Obstetrics and Gynaecology, Queen Mary
Hospital, University of Hong Kong
Funding: PPSW received financial support from the Graduate School,
University of Hong Kong.
Conflicts of interest: none.
REFERENCES
1 Department of Health. Annual report 2002/2003. Hong Kong: Government
Printers, 2003.
2 Osmond C, Gardner MJ. Age, period and cohort models applied to cancer
mortality rates. Stat Med 1982;1:245–59.
3 Zheng T, Mayne ST, Holford TR, et al. The time trend and age-period-cohort
effects on incidence of oesophageal cancer in Connecticut, 1935–89. Cancer
Causes Control 1992;3:481–92.
4 Adami HO, Bergstrom R, Sparen P, et al. Increasing cancer risk in younger
birth cohorts in Sweden. Lancet 1993;341:773–7.
5 Persson I, Bergstrom R, Sparen P, et al. Trends in breast cancer incidence in
Sweden 1958–1988 by time period and birth cohort. Br J Cancer
1993;68:1247–53.
6 Leung GM, Thach TQ, Lam TH, et al. Trends in breast cancer incidence in
Hong Kong between 1973 and 1999: an age-period-cohort analysis.
Br J Cancer 2002;87:982–8.
7 Wang PD, Lin RS. Age-period-cohort analysis of cervical cancer mortality in
Taiwan, 1974–1992. Acta Obstet Gynecol Scand 1997;76:697–702.
8 Sasieni P, Adams J. Effect of screening on cervical cancer mortality in England
and Wales: analysis of trends with an age period cohort model. BMJ
1999;318:1244–5.
9 Hong Kong Cancer Registry. Cancer incidence and mortality in Hong Kong
1995–1996. Hong Kong: Hospital Authority, 1999.
718 Leung, Woo, McGhee, et al
www.jech.com
 on 1 March 2007 jech.bmj.comDownloaded from 
10 Segi M. Cancer mortality for selected sites in 24 countries (1950–1957).
Sendai, Japan: Tohoku University Press, 1960.
11 Tarone RE, Chu K. Implications of birth cohort patterns in interpreting trends in
breast cancer rates. J Natl Cancer Inst 1992;84:1402–10.
12 Clayton D, Schifflers E, Models for temporal variation in cancer rates I: age-
period and age-cohort models. Stat Med 1987;6:449–67.
13 Clayton D, Schifflers E. Models for temporal variation in cancer rates II: age-
period-cohort models. Stat Med 1987;6:469–81.
14 Holford TR. The estimation of age, period, and cohort effects for vital rates.
Biometrics 1983;39:311–24.
15 Holford TR. Understanding the effects of age, period, and cohort on incidence
and mortality rates. Annu Rev Public Health 1991;12:425–57.
16 Tarone RE, Chu K. Evaluation of birth cohort patterns in population disease
rates. Am J Epidemiol 1996;143:85–91.
17 Shahpar C, Li G. Homicidal mortality in the United States, 1935–1994: age,
period and cohort effects. Am J Epidemiol 1999;125:1213–22.
18 McCullagh P, Nelder J. Generalised linear models. 2nd ed. London:
Chapman and Hall, 1983.
19 Knorr-Held L, Rainer E. Prognosis of lung cancer mortality in West Germany:
a case study in Bayesian prediction. Biostat 2001;2:109–29.
20 The University of Hong Kong. Population health survey report. Hong Kong:
Department of Health, Government of the Hong Kong Special Administrative
Region, People’s Republic of China, 2005.
21 Adab P, McGhee SM, Yanova J, et al. Effectiveness and efficiency of
opportunistic cervical cancer screening: comparison with organized
screening. Med Care 2004;42:600–9.
22 Hong Kong Census and Statistics Department. Thematic household survey
report no 12. Hong Kong: Government Printers, 2003.
23 Leung GM, Lam TH, Thach TQ, et al. Rates of cesarean births in Hong Kong:
1987–1999. Birth 2001;28:166–72.
24 Hong Kong Census and Statistics Department. Total live births by age of
mother. In: Hong Kong annual digest of statistics 1972–2002. Hong Kong:
Government Printers, 1973–2003.
25 Anttila A, Nieminen P. Cervical cancer screening programme in Finland.
Eur J Cancer 2000;36:2209–14.
26 Snider J, Beauvais J, Levy I, et al. Trends in mammography and pap smear
utilization in Canada. Chronic diseases in Canada 1996;17:108–17.
27 Breen N, Kessler L. Trends in cancer screening—United States, 1987 and
1992. MMWR Morb Mort Wkly Rep 1995;45:57–61.
28 Department of Health. Cervical screening programme, England: 1994–95 to
1996–97. London Department of Health (Statistical bulletins 1996/3, 1996/
26, 1997/27).
29 Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human
papillomavirus and cervical cancer. J Clin Pathol 2002;55:244–65.
30 Franco EL, Schlecht NF, Saslow D. The epidemiology of cervical cancer.
Cancer J 2003;9:348–59.
31 The Family Planning Association of Hong Kong. Report on the survey family
planning in Hong Kong: knowledge, attitude and practice in 1967, 1972,
1977, 1982, 1987, 1992, 1997 and 2002.
32 The Family Planning Association of Hong Kong. Youth sexuality study reports
in 1981, 1986, 1991, 1996 and 2001.
33 Bekkers RLM, Massuger LFAG, Bulten J, et al. Epidemiological and clinical
aspects of human papillomavirus detection in the prevention of cervical
cancer. Rev Med Virol 2004;14:95–105.
34 Chan PK, Chang AR, Cheung JL, et al. Determinants of cervical human
papillomavirus infection: differences between high- and low-oncogenic risk
types. J Infect Dis 2002;185:28–35.
35 Lo KW, Wong YF, Chan MK, et al. Prevalence of human papillomavirus in
cervical cancer: a multicenter study in China. Int J Cancer 2002;100:327–31.
36 Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus
in cervical cancer: a worldwide perspective. International biological study on
cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796–802.
37 Lynge E, Madsen M, Engholm G. Effect of organized screening on incidence
and mortality of cervical cancer in Denmark. Cancer Res 1989;49:2157–60.
38 Nieminen P, Kallio M, Anttila A, et al. Organized versus spontaneous pap-
smear screening for cervical cancer, a case control study. Int J Cancer
1999;83:55–8.
39 Peto J, Gilham C, Fletcher O, et al. The cervical cancer epidemic that
screening has prevented in the UK. Lancet 2004;364:249–56.
40 Paloma VA, Moreno V, Bosch F, et al. International trends in incidence of
cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas.
Int J Cancer 1998;75:536–45.
41 Paloma VA, Moreno V, Bosch F, et al. International trends in incidence of
cervical cancer: II. Squamous-cell carcinoma. Int J Cancer 2000;86:429–35.
APPENDIX
Hong Kong launched a quasi organised screening programme
in March 2004 (http://www.cervicalscreening.gov.hk/).
Because of resource constraints, this government operated
programme mainly provides a prospective record and recall
function for those who have ever been screened. The
programme encourages women to undergo regular cytologi-
cal examination through social marketing campaigns for the
general public and via primary care and women’s health
providers to women on an opportunisitic basis. For those
women who decide to get screened, they can seek to be tested
at public or private care providers on a full fee for service
basis using either traditional Pap smear or liquid based
method with/without human papillomavirus (HPV) testing.
These providers are then encouraged to enter the screened
woman’s details into a centralised database for subsequent
automatic recall (every three years) and archiving of test
results. Therefore, without explicitly anchoring the pro-
gramme with proactive, personalised invitation to be
screened (initial ‘‘call’’ function) and direct provision of
Pap testing at dedicated facilities for a reasonable fee (as
compared with full market rates), it is a suboptimal
arrangement compared with standard practice in Canada,
UK, and other European countries, for example.
Nevertheless, referral for colpolscopy and subsequent man-
agement in the case of invasive disease are available in both
the public and private sectors, where the former essentially
provides universal access to all services with minimal
copayments (amounting to an all inclusive daily charge of
less than £7 or US$13) at the point of care. Indeed, the public
sector provides 95% of total bed days for all inpatient care
locally. As at March 2005 after 12 months in operation, just
under 120 000 (4.8%) women out of a potentially eligible
female population of 2.5 million aged 21 to 69 years have
been registered, even though we know that between 42% to
60% of local women reported being ever screened in the past
five years. It remains to be seen whether the projected
benefits of organised screening can be realised, perhaps with
modification and enhancements subsequently to the present
programme arrangements.
Table A1 Age standardised (world standard population) and age specific incidence rates (per 100 000 women) of cervical
cancer in Hong Kong, 1972–2001
Age (years)
Time period (calendar year)
1972–76 1977–81 1982–86 1987–91 1992–96 1997–2001
25–29 4.05 (28) 6.37 (66) 3.78 (52) 2.57 (39) 2.14 (31) 2.15 (31)
30–34 16.65 (76) 17.26 (129) 11.74 (131) 9.66(137) 6.25 (104) 7.49 (123)
35–39 29.81 (164) 35.07 (172) 20.28 (163) 16.43 (188) 15.17 (228) 12.54 (225)
40–44 51.17 (314) 40.90 (237) 33.63 (183) 28.99 (236) 21.06 (249) 16.82 (265)
45–49 65.45 (390) 58.87 (364) 46.08 (280) 34.30 (188) 27.54 (230) 19.76 (243)
50–54 76.57 (404) 75.55 (453) 61.60 (389) 38.76 (234) 34.00 (187) 29.04 (249)
55–59 77.64 (342) 89.17 (458) 64.68 (379) 50.25 (311) 40.76 (245) 25.93 (144)
60–64 84.58 (310) 86.66 (378) 83.29 (420) 56.18 (320) 43.98 (270) 33.35 (205)
65–69 82.47 (223) 79.45 (275) 61.21 (252) 57.87 (271) 48.18 (265) 38.82 (237)
70–74 70.62 (149) 72.00 (184) 62.47 (198) 62.20 (225) 48.80 (210) 39.18 (201)
75–79 63.73 (84) 70.74 (123) 47.96 (99) 46.52 (116) 51.58 (158) 50.61 (192)
80–84 40.35 (28) 63.05 (59) 51.24 (64) 48.95 (68) 48.34 (88) 42.52 (100)
Age standardised 25.90 26.02 20.21 15.81 12.94 10.29
Number of cases on which rates are based are in parentheses.
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Figure A1 Observed and fitted number of cervical cancer cases with associated 90% credible regions for selected age groups in Hong Kong, 1972–
2001.
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Figure A2 Proportion of Hong Kong
female population ever screened and
undergoing regular cytological
examination by age (birth cohort). *As
at 2003. Assuming median age of first
pregnancy is 29 years24 and Pap smear
became a routine part of antenatal
diagnostics starting from 1980.
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